Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 206-120-1 | 11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) | 302-25-0 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Repr. 1B | H360 (D) | H360 (D) |
GHS08 Dgr |
 |
State/Form
|
1 | |
View details | |||
| Repr. 2 | H361 | H361 |
GHS08 Wng |
State/Form
|
1 | |
View details | ||||
| Repr. 2 | H361 | H361 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| STOT RE 2 | H373 (Adrenergic and ...) (oral) | H373 | |||||||||
| STOT RE 2 | H373 (other:Adrenergi...) (oral) | H373 | |||||||||
Number of Aggregated Notifications: 3